nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—Loss of libido—Lovastatin—atherosclerosis	0.0146	0.0232	CcSEcCtD
Atropine—Loss of libido—Simvastatin—atherosclerosis	0.0136	0.0217	CcSEcCtD
Atropine—Loss of libido—Pravastatin—atherosclerosis	0.0123	0.0197	CcSEcCtD
Atropine—Blood disorder—Rosuvastatin—atherosclerosis	0.00951	0.0152	CcSEcCtD
Atropine—Heartburn—Niacin—atherosclerosis	0.0084	0.0134	CcSEcCtD
Atropine—Heartburn—Pravastatin—atherosclerosis	0.00827	0.0132	CcSEcCtD
Atropine—Laryngitis—Niacin—atherosclerosis	0.00802	0.0128	CcSEcCtD
Atropine—Laryngospasm—Niacin—atherosclerosis	0.00774	0.0123	CcSEcCtD
Atropine—Feeling hot—Niacin—atherosclerosis	0.00736	0.0117	CcSEcCtD
Atropine—Gastrooesophageal reflux disease—Ezetimibe—atherosclerosis	0.00731	0.0117	CcSEcCtD
Atropine—Hypertonia—Rosuvastatin—atherosclerosis	0.00696	0.0111	CcSEcCtD
Atropine—Amnesia—Rosuvastatin—atherosclerosis	0.00613	0.00979	CcSEcCtD
Atropine—Muscle twitching—Niacin—atherosclerosis	0.00588	0.00939	CcSEcCtD
Atropine—Dermatitis contact—Niacin—atherosclerosis	0.00571	0.00911	CcSEcCtD
Atropine—Skin exfoliation—Niacin—atherosclerosis	0.00552	0.0088	CcSEcCtD
Atropine—Rash maculo-papular—Niacin—atherosclerosis	0.00525	0.00838	CcSEcCtD
Atropine—Amnesia—Lovastatin—atherosclerosis	0.0052	0.00829	CcSEcCtD
Atropine—Swelling—Simvastatin—atherosclerosis	0.00518	0.00826	CcSEcCtD
Atropine—Amnesia—Ezetimibe—atherosclerosis	0.0051	0.00813	CcSEcCtD
Atropine—Eczema—Simvastatin—atherosclerosis	0.00508	0.00811	CcSEcCtD
Atropine—Hypertonia—Niacin—atherosclerosis	0.00507	0.00808	CcSEcCtD
Atropine—Amnesia—Simvastatin—atherosclerosis	0.00486	0.00776	CcSEcCtD
Atropine—Atrial fibrillation—Simvastatin—atherosclerosis	0.00482	0.00769	CcSEcCtD
Atropine—Eczema—Niacin—atherosclerosis	0.00467	0.00745	CcSEcCtD
Atropine—Depression—Rosuvastatin—atherosclerosis	0.00443	0.00706	CcSEcCtD
Atropine—Atrial fibrillation—Niacin—atherosclerosis	0.00443	0.00706	CcSEcCtD
Atropine—Amnesia—Pravastatin—atherosclerosis	0.0044	0.00701	CcSEcCtD
Atropine—Urinary retention—Niacin—atherosclerosis	0.00399	0.00636	CcSEcCtD
Atropine—Erectile dysfunction—Lovastatin—atherosclerosis	0.00389	0.0062	CcSEcCtD
Atropine—Dry skin—Niacin—atherosclerosis	0.00384	0.00613	CcSEcCtD
Atropine—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00381	0.00608	CcSEcCtD
Atropine—Dry skin—Pravastatin—atherosclerosis	0.00379	0.00604	CcSEcCtD
Atropine—Abdominal distension—Niacin—atherosclerosis	0.00365	0.00582	CcSEcCtD
Atropine—Erectile dysfunction—Simvastatin—atherosclerosis	0.00364	0.0058	CcSEcCtD
Atropine—Dysphagia—Niacin—atherosclerosis	0.00363	0.00578	CcSEcCtD
Atropine—Abdominal distension—Pravastatin—atherosclerosis	0.00359	0.00573	CcSEcCtD
Atropine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00356	0.00568	CcSEcCtD
Atropine—Angina pectoris—Niacin—atherosclerosis	0.00353	0.00563	CcSEcCtD
Atropine—Depression—Simvastatin—atherosclerosis	0.00351	0.0056	CcSEcCtD
Atropine—Mental disorder—Rosuvastatin—atherosclerosis	0.00349	0.00557	CcSEcCtD
Atropine—Angina pectoris—Pravastatin—atherosclerosis	0.00348	0.00555	CcSEcCtD
Atropine—Erectile dysfunction—Niacin—atherosclerosis	0.00334	0.00533	CcSEcCtD
Atropine—Dysuria—Pravastatin—atherosclerosis	0.00334	0.00532	CcSEcCtD
Atropine—Erectile dysfunction—Pravastatin—atherosclerosis	0.00329	0.00524	CcSEcCtD
Atropine—Depression—Pravastatin—atherosclerosis	0.00317	0.00506	CcSEcCtD
Atropine—Angioedema—Rosuvastatin—atherosclerosis	0.00317	0.00506	CcSEcCtD
Atropine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00314	0.00501	CcSEcCtD
Atropine—Flushing—Lovastatin—atherosclerosis	0.00314	0.005	CcSEcCtD
Atropine—Myocardial infarction—Pravastatin—atherosclerosis	0.00312	0.00498	CcSEcCtD
Atropine—Sweating—Niacin—atherosclerosis	0.0031	0.00494	CcSEcCtD
Atropine—Flushing—Ezetimibe—atherosclerosis	0.00308	0.00491	CcSEcCtD
Atropine—Flushing—Simvastatin—atherosclerosis	0.00293	0.00468	CcSEcCtD
Atropine—Mental disorder—Ezetimibe—atherosclerosis	0.0029	0.00463	CcSEcCtD
Atropine—Erythema—Ezetimibe—atherosclerosis	0.00288	0.0046	CcSEcCtD
Atropine—Dysgeusia—Lovastatin—atherosclerosis	0.00288	0.00459	CcSEcCtD
Atropine—Confusional state—Rosuvastatin—atherosclerosis	0.00286	0.00456	CcSEcCtD
Atropine—Vision blurred—Lovastatin—atherosclerosis	0.00277	0.00442	CcSEcCtD
Atropine—Mental disorder—Simvastatin—atherosclerosis	0.00277	0.00442	CcSEcCtD
Atropine—Erythema—Simvastatin—atherosclerosis	0.00275	0.00439	CcSEcCtD
Atropine—Dysgeusia—Simvastatin—atherosclerosis	0.00269	0.0043	CcSEcCtD
Atropine—Flushing—Niacin—atherosclerosis	0.00269	0.0043	CcSEcCtD
Atropine—Angioedema—Lovastatin—atherosclerosis	0.00269	0.00429	CcSEcCtD
Atropine—Flushing—Pravastatin—atherosclerosis	0.00265	0.00423	CcSEcCtD
Atropine—Vertigo—Lovastatin—atherosclerosis	0.00264	0.00422	CcSEcCtD
Atropine—Angioedema—Ezetimibe—atherosclerosis	0.00264	0.00421	CcSEcCtD
Atropine—Benzatropine—HRH1—atherosclerosis	0.0026	1	CrCbGaD
Atropine—Vision blurred—Simvastatin—atherosclerosis	0.00259	0.00414	CcSEcCtD
Atropine—Arrhythmia—Niacin—atherosclerosis	0.00259	0.00414	CcSEcCtD
Atropine—Insomnia—Rosuvastatin—atherosclerosis	0.00256	0.00409	CcSEcCtD
Atropine—Arrhythmia—Pravastatin—atherosclerosis	0.00255	0.00407	CcSEcCtD
Atropine—Palpitations—Ezetimibe—atherosclerosis	0.00255	0.00407	CcSEcCtD
Atropine—Erythema—Niacin—atherosclerosis	0.00253	0.00403	CcSEcCtD
Atropine—Angioedema—Simvastatin—atherosclerosis	0.00251	0.00401	CcSEcCtD
Atropine—Chest pain—Lovastatin—atherosclerosis	0.0025	0.00399	CcSEcCtD
Atropine—Anxiety—Lovastatin—atherosclerosis	0.0025	0.00398	CcSEcCtD
Atropine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00249	0.00398	CcSEcCtD
Atropine—Tension—Niacin—atherosclerosis	0.00248	0.00395	CcSEcCtD
Atropine—Vertigo—Simvastatin—atherosclerosis	0.00247	0.00394	CcSEcCtD
Atropine—Chest pain—Ezetimibe—atherosclerosis	0.00246	0.00392	CcSEcCtD
Atropine—Nervousness—Niacin—atherosclerosis	0.00245	0.00391	CcSEcCtD
Atropine—Dry mouth—Lovastatin—atherosclerosis	0.00245	0.00391	CcSEcCtD
Atropine—Tension—Pravastatin—atherosclerosis	0.00244	0.00389	CcSEcCtD
Atropine—Dysgeusia—Pravastatin—atherosclerosis	0.00244	0.00389	CcSEcCtD
Atropine—Pain—Rosuvastatin—atherosclerosis	0.00242	0.00386	CcSEcCtD
Atropine—Constipation—Rosuvastatin—atherosclerosis	0.00242	0.00386	CcSEcCtD
Atropine—Confusional state—Lovastatin—atherosclerosis	0.00242	0.00386	CcSEcCtD
Atropine—Nervousness—Pravastatin—atherosclerosis	0.00242	0.00385	CcSEcCtD
Atropine—Dry mouth—Ezetimibe—atherosclerosis	0.0024	0.00383	CcSEcCtD
Atropine—Anaphylactic shock—Lovastatin—atherosclerosis	0.0024	0.00383	CcSEcCtD
Atropine—Vision blurred—Niacin—atherosclerosis	0.00238	0.0038	CcSEcCtD
Atropine—Confusional state—Ezetimibe—atherosclerosis	0.00237	0.00379	CcSEcCtD
Atropine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00235	0.00376	CcSEcCtD
Atropine—Vision blurred—Pravastatin—atherosclerosis	0.00234	0.00374	CcSEcCtD
Atropine—Chest pain—Simvastatin—atherosclerosis	0.00234	0.00374	CcSEcCtD
Atropine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00233	0.00372	CcSEcCtD
Atropine—Anxiety—Simvastatin—atherosclerosis	0.00233	0.00372	CcSEcCtD
Atropine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00232	0.0037	CcSEcCtD
Atropine—Angioedema—Niacin—atherosclerosis	0.00231	0.00368	CcSEcCtD
Atropine—Angioedema—Pravastatin—atherosclerosis	0.00227	0.00363	CcSEcCtD
Atropine—Vertigo—Niacin—atherosclerosis	0.00227	0.00362	CcSEcCtD
Atropine—Syncope—Niacin—atherosclerosis	0.00227	0.00361	CcSEcCtD
Atropine—Confusional state—Simvastatin—atherosclerosis	0.00226	0.00361	CcSEcCtD
Atropine—Urticaria—Rosuvastatin—atherosclerosis	0.00225	0.00359	CcSEcCtD
Atropine—Anaphylactic shock—Simvastatin—atherosclerosis	0.00225	0.00358	CcSEcCtD
Atropine—Oedema—Simvastatin—atherosclerosis	0.00225	0.00358	CcSEcCtD
Atropine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00224	0.00357	CcSEcCtD
Atropine—Vertigo—Pravastatin—atherosclerosis	0.00223	0.00356	CcSEcCtD
Atropine—Palpitations—Niacin—atherosclerosis	0.00223	0.00356	CcSEcCtD
Atropine—Loss of consciousness—Niacin—atherosclerosis	0.00222	0.00354	CcSEcCtD
Atropine—Insomnia—Lovastatin—atherosclerosis	0.00217	0.00346	CcSEcCtD
Atropine—Dyspnoea—Lovastatin—atherosclerosis	0.00214	0.00341	CcSEcCtD
Atropine—Insomnia—Ezetimibe—atherosclerosis	0.00213	0.0034	CcSEcCtD
Atropine—Chest pain—Pravastatin—atherosclerosis	0.00212	0.00338	CcSEcCtD
Atropine—Dyspepsia—Lovastatin—atherosclerosis	0.00211	0.00337	CcSEcCtD
Atropine—Anxiety—Pravastatin—atherosclerosis	0.00211	0.00337	CcSEcCtD
Atropine—Dry mouth—Niacin—atherosclerosis	0.0021	0.00336	CcSEcCtD
Atropine—Dyspnoea—Ezetimibe—atherosclerosis	0.0021	0.00335	CcSEcCtD
Atropine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00209	0.00333	CcSEcCtD
Atropine—Dyspepsia—Ezetimibe—atherosclerosis	0.00207	0.00331	CcSEcCtD
Atropine—Fatigue—Lovastatin—atherosclerosis	0.00207	0.0033	CcSEcCtD
Atropine—Anaphylactic shock—Niacin—atherosclerosis	0.00206	0.00329	CcSEcCtD
Atropine—Oedema—Niacin—atherosclerosis	0.00206	0.00329	CcSEcCtD
Atropine—Pain—Lovastatin—atherosclerosis	0.00205	0.00327	CcSEcCtD
Atropine—Constipation—Lovastatin—atherosclerosis	0.00205	0.00327	CcSEcCtD
Atropine—Confusional state—Pravastatin—atherosclerosis	0.00205	0.00327	CcSEcCtD
Atropine—Asthenia—Rosuvastatin—atherosclerosis	0.00203	0.00324	CcSEcCtD
Atropine—Insomnia—Simvastatin—atherosclerosis	0.00203	0.00324	CcSEcCtD
Atropine—Anaphylactic shock—Pravastatin—atherosclerosis	0.00203	0.00324	CcSEcCtD
Atropine—Oedema—Pravastatin—atherosclerosis	0.00203	0.00324	CcSEcCtD
Atropine—Fatigue—Ezetimibe—atherosclerosis	0.00203	0.00324	CcSEcCtD
Atropine—Shock—Niacin—atherosclerosis	0.00203	0.00324	CcSEcCtD
Atropine—Pain—Ezetimibe—atherosclerosis	0.00201	0.00321	CcSEcCtD
Atropine—Constipation—Ezetimibe—atherosclerosis	0.00201	0.00321	CcSEcCtD
Atropine—Tachycardia—Niacin—atherosclerosis	0.00201	0.00321	CcSEcCtD
Atropine—Pruritus—Rosuvastatin—atherosclerosis	0.002	0.0032	CcSEcCtD
Atropine—Dyspnoea—Simvastatin—atherosclerosis	0.002	0.00319	CcSEcCtD
Atropine—Hyperhidrosis—Niacin—atherosclerosis	0.00199	0.00318	CcSEcCtD
Atropine—Feeling abnormal—Lovastatin—atherosclerosis	0.00198	0.00316	CcSEcCtD
Atropine—Dyspepsia—Simvastatin—atherosclerosis	0.00198	0.00315	CcSEcCtD
Atropine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00196	0.00313	CcSEcCtD
Atropine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00196	0.00313	CcSEcCtD
Atropine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00194	0.0031	CcSEcCtD
Atropine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00194	0.00309	CcSEcCtD
Atropine—Fatigue—Simvastatin—atherosclerosis	0.00194	0.00309	CcSEcCtD
Atropine—Hypotension—Niacin—atherosclerosis	0.00193	0.00307	CcSEcCtD
Atropine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00193	0.00307	CcSEcCtD
Atropine—Pain—Simvastatin—atherosclerosis	0.00192	0.00306	CcSEcCtD
Atropine—Constipation—Simvastatin—atherosclerosis	0.00192	0.00306	CcSEcCtD
Atropine—Urticaria—Lovastatin—atherosclerosis	0.00191	0.00304	CcSEcCtD
Atropine—Abdominal pain—Lovastatin—atherosclerosis	0.0019	0.00303	CcSEcCtD
Atropine—Body temperature increased—Lovastatin—atherosclerosis	0.0019	0.00303	CcSEcCtD
Atropine—Dizziness—Rosuvastatin—atherosclerosis	0.00187	0.00299	CcSEcCtD
Atropine—Urticaria—Ezetimibe—atherosclerosis	0.00187	0.00298	CcSEcCtD
Atropine—Insomnia—Niacin—atherosclerosis	0.00186	0.00297	CcSEcCtD
Atropine—Abdominal pain—Ezetimibe—atherosclerosis	0.00186	0.00297	CcSEcCtD
Atropine—Body temperature increased—Ezetimibe—atherosclerosis	0.00186	0.00297	CcSEcCtD
Atropine—Feeling abnormal—Simvastatin—atherosclerosis	0.00185	0.00295	CcSEcCtD
Atropine—Dyspnoea—Niacin—atherosclerosis	0.00184	0.00293	CcSEcCtD
Atropine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00184	0.00293	CcSEcCtD
Atropine—Insomnia—Pravastatin—atherosclerosis	0.00184	0.00293	CcSEcCtD
Atropine—Somnolence—Niacin—atherosclerosis	0.00183	0.00292	CcSEcCtD
Atropine—Dyspepsia—Niacin—atherosclerosis	0.00181	0.0029	CcSEcCtD
Atropine—Dyspnoea—Pravastatin—atherosclerosis	0.00181	0.00289	CcSEcCtD
Atropine—Dyspepsia—Pravastatin—atherosclerosis	0.00179	0.00285	CcSEcCtD
Atropine—Rash—Rosuvastatin—atherosclerosis	0.00179	0.00285	CcSEcCtD
Atropine—Dermatitis—Rosuvastatin—atherosclerosis	0.00178	0.00285	CcSEcCtD
Atropine—Urticaria—Simvastatin—atherosclerosis	0.00178	0.00285	CcSEcCtD
Atropine—Abdominal pain—Simvastatin—atherosclerosis	0.00177	0.00283	CcSEcCtD
Atropine—Body temperature increased—Simvastatin—atherosclerosis	0.00177	0.00283	CcSEcCtD
Atropine—Headache—Rosuvastatin—atherosclerosis	0.00177	0.00283	CcSEcCtD
Atropine—Hypersensitivity—Lovastatin—atherosclerosis	0.00177	0.00282	CcSEcCtD
Atropine—Pain—Niacin—atherosclerosis	0.00176	0.00281	CcSEcCtD
Atropine—Fatigue—Pravastatin—atherosclerosis	0.00175	0.00279	CcSEcCtD
Atropine—Pain—Pravastatin—atherosclerosis	0.00174	0.00277	CcSEcCtD
Atropine—Constipation—Pravastatin—atherosclerosis	0.00174	0.00277	CcSEcCtD
Atropine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00173	0.00277	CcSEcCtD
Atropine—Asthenia—Lovastatin—atherosclerosis	0.00172	0.00275	CcSEcCtD
Atropine—Pruritus—Lovastatin—atherosclerosis	0.0017	0.00271	CcSEcCtD
Atropine—Asthenia—Ezetimibe—atherosclerosis	0.00169	0.00269	CcSEcCtD
Atropine—Gastrointestinal pain—Niacin—atherosclerosis	0.00169	0.00269	CcSEcCtD
Atropine—Nausea—Rosuvastatin—atherosclerosis	0.00168	0.00268	CcSEcCtD
Atropine—Feeling abnormal—Pravastatin—atherosclerosis	0.00167	0.00267	CcSEcCtD
Atropine—Pruritus—Ezetimibe—atherosclerosis	0.00167	0.00266	CcSEcCtD
Atropine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00166	0.00265	CcSEcCtD
Atropine—Hypersensitivity—Simvastatin—atherosclerosis	0.00165	0.00264	CcSEcCtD
Atropine—Diarrhoea—Lovastatin—atherosclerosis	0.00164	0.00262	CcSEcCtD
Atropine—Urticaria—Niacin—atherosclerosis	0.00164	0.00261	CcSEcCtD
Atropine—Abdominal pain—Niacin—atherosclerosis	0.00163	0.0026	CcSEcCtD
Atropine—Body temperature increased—Niacin—atherosclerosis	0.00163	0.0026	CcSEcCtD
Atropine—Urticaria—Pravastatin—atherosclerosis	0.00161	0.00257	CcSEcCtD
Atropine—Asthenia—Simvastatin—atherosclerosis	0.00161	0.00257	CcSEcCtD
Atropine—Diarrhoea—Ezetimibe—atherosclerosis	0.00161	0.00257	CcSEcCtD
Atropine—Abdominal pain—Pravastatin—atherosclerosis	0.0016	0.00256	CcSEcCtD
Atropine—Body temperature increased—Pravastatin—atherosclerosis	0.0016	0.00256	CcSEcCtD
Atropine—Pruritus—Simvastatin—atherosclerosis	0.00159	0.00253	CcSEcCtD
Atropine—Dizziness—Lovastatin—atherosclerosis	0.00159	0.00253	CcSEcCtD
Atropine—Dizziness—Ezetimibe—atherosclerosis	0.00156	0.00248	CcSEcCtD
Atropine—Diarrhoea—Simvastatin—atherosclerosis	0.00154	0.00245	CcSEcCtD
Atropine—Vomiting—Lovastatin—atherosclerosis	0.00153	0.00243	CcSEcCtD
Atropine—Hypersensitivity—Niacin—atherosclerosis	0.00152	0.00242	CcSEcCtD
Atropine—Rash—Lovastatin—atherosclerosis	0.00151	0.00241	CcSEcCtD
Atropine—Dermatitis—Lovastatin—atherosclerosis	0.00151	0.00241	CcSEcCtD
Atropine—Headache—Lovastatin—atherosclerosis	0.0015	0.0024	CcSEcCtD
Atropine—Vomiting—Ezetimibe—atherosclerosis	0.0015	0.00239	CcSEcCtD
Atropine—Hypersensitivity—Pravastatin—atherosclerosis	0.0015	0.00239	CcSEcCtD
Atropine—Dizziness—Simvastatin—atherosclerosis	0.00148	0.00237	CcSEcCtD
Atropine—Rash—Ezetimibe—atherosclerosis	0.00148	0.00237	CcSEcCtD
Atropine—Dermatitis—Ezetimibe—atherosclerosis	0.00148	0.00237	CcSEcCtD
Atropine—Asthenia—Niacin—atherosclerosis	0.00148	0.00236	CcSEcCtD
Atropine—Headache—Ezetimibe—atherosclerosis	0.00147	0.00235	CcSEcCtD
Atropine—Pruritus—Niacin—atherosclerosis	0.00146	0.00233	CcSEcCtD
Atropine—Asthenia—Pravastatin—atherosclerosis	0.00146	0.00232	CcSEcCtD
Atropine—Pruritus—Pravastatin—atherosclerosis	0.00144	0.00229	CcSEcCtD
Atropine—Vomiting—Simvastatin—atherosclerosis	0.00143	0.00228	CcSEcCtD
Atropine—Nausea—Lovastatin—atherosclerosis	0.00143	0.00227	CcSEcCtD
Atropine—Rash—Simvastatin—atherosclerosis	0.00142	0.00226	CcSEcCtD
Atropine—Dermatitis—Simvastatin—atherosclerosis	0.00141	0.00226	CcSEcCtD
Atropine—Diarrhoea—Niacin—atherosclerosis	0.00141	0.00225	CcSEcCtD
Atropine—Headache—Simvastatin—atherosclerosis	0.00141	0.00224	CcSEcCtD
Atropine—Nausea—Ezetimibe—atherosclerosis	0.0014	0.00223	CcSEcCtD
Atropine—Diarrhoea—Pravastatin—atherosclerosis	0.00139	0.00222	CcSEcCtD
Atropine—Dizziness—Niacin—atherosclerosis	0.00136	0.00217	CcSEcCtD
Atropine—Dizziness—Pravastatin—atherosclerosis	0.00134	0.00214	CcSEcCtD
Atropine—Nausea—Simvastatin—atherosclerosis	0.00133	0.00213	CcSEcCtD
Atropine—Vomiting—Niacin—atherosclerosis	0.00131	0.00209	CcSEcCtD
Atropine—Rash—Niacin—atherosclerosis	0.0013	0.00207	CcSEcCtD
Atropine—Dermatitis—Niacin—atherosclerosis	0.0013	0.00207	CcSEcCtD
Atropine—Headache—Niacin—atherosclerosis	0.00129	0.00206	CcSEcCtD
Atropine—Vomiting—Pravastatin—atherosclerosis	0.00129	0.00206	CcSEcCtD
Atropine—Rash—Pravastatin—atherosclerosis	0.00128	0.00204	CcSEcCtD
Atropine—Dermatitis—Pravastatin—atherosclerosis	0.00128	0.00204	CcSEcCtD
Atropine—Headache—Pravastatin—atherosclerosis	0.00127	0.00203	CcSEcCtD
Atropine—Nausea—Niacin—atherosclerosis	0.00122	0.00195	CcSEcCtD
Atropine—Nausea—Pravastatin—atherosclerosis	0.00121	0.00192	CcSEcCtD
Atropine—CHRM3—Metabolism—HMOX1—atherosclerosis	8.49e-05	0.000229	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PDGFB—atherosclerosis	8.47e-05	0.000229	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ABCG5—atherosclerosis	8.4e-05	0.000227	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	8.4e-05	0.000227	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	8.35e-05	0.000225	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	8.32e-05	0.000224	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—AGT—atherosclerosis	8.27e-05	0.000223	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	8.24e-05	0.000222	CbGpPWpGaD
Atropine—CHRM3—Metabolism—APOB—atherosclerosis	8.14e-05	0.00022	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—LPA—atherosclerosis	8.12e-05	0.000219	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PDGFB—atherosclerosis	8.11e-05	0.000219	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—LEP—atherosclerosis	8.1e-05	0.000219	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—APOE—atherosclerosis	8.1e-05	0.000219	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CAV1—atherosclerosis	8.03e-05	0.000217	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—APOA1—atherosclerosis	8.01e-05	0.000216	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KNG1—atherosclerosis	7.97e-05	0.000215	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KNG1—atherosclerosis	7.94e-05	0.000214	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	7.92e-05	0.000214	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—AGT—atherosclerosis	7.92e-05	0.000214	CbGpPWpGaD
Atropine—CHRM3—Metabolism—GSTM1—atherosclerosis	7.91e-05	0.000214	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	7.9e-05	0.000213	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KNG1—atherosclerosis	7.87e-05	0.000212	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—BGN—atherosclerosis	7.86e-05	0.000212	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	7.82e-05	0.000211	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	7.81e-05	0.000211	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—APOA5—atherosclerosis	7.78e-05	0.00021	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	7.77e-05	0.00021	CbGpPWpGaD
Atropine—CHRM3—Metabolism—LPL—atherosclerosis	7.77e-05	0.00021	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—LEP—atherosclerosis	7.76e-05	0.000209	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—APOE—atherosclerosis	7.76e-05	0.000209	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	7.75e-05	0.000209	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—ESR1—atherosclerosis	7.73e-05	0.000209	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PLG—atherosclerosis	7.72e-05	0.000208	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PLG—atherosclerosis	7.7e-05	0.000208	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CAV1—atherosclerosis	7.69e-05	0.000207	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	7.67e-05	0.000207	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—APOA1—atherosclerosis	7.67e-05	0.000207	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—F2—atherosclerosis	7.64e-05	0.000206	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PLG—atherosclerosis	7.62e-05	0.000206	CbGpPWpGaD
Atropine—CHRM3—Metabolism—GPX1—atherosclerosis	7.58e-05	0.000205	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	7.56e-05	0.000204	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	7.49e-05	0.000202	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—ESR1—atherosclerosis	7.41e-05	0.0002	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.41e-05	0.0002	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CD36—atherosclerosis	7.38e-05	0.000199	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.34e-05	0.000198	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.32e-05	0.000198	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—F2—atherosclerosis	7.32e-05	0.000197	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	7.31e-05	0.000197	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CG—atherosclerosis	7.31e-05	0.000197	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	7.29e-05	0.000197	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ALOX5—atherosclerosis	7.24e-05	0.000195	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	7.22e-05	0.000195	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MMP3—atherosclerosis	7.06e-05	0.000191	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MMP3—atherosclerosis	7.04e-05	0.00019	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IGF2—atherosclerosis	7.03e-05	0.00019	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IGF2—atherosclerosis	7.01e-05	0.000189	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—MAPK3—atherosclerosis	7e-05	0.000189	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CG—atherosclerosis	7e-05	0.000189	CbGpPWpGaD
Atropine—CHRM3—Metabolism—MTHFR—atherosclerosis	6.99e-05	0.000189	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MMP3—atherosclerosis	6.97e-05	0.000188	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IGF2—atherosclerosis	6.94e-05	0.000187	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—INS—atherosclerosis	6.92e-05	0.000187	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PPARA—atherosclerosis	6.86e-05	0.000185	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—APOB—atherosclerosis	6.83e-05	0.000184	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCL2—atherosclerosis	6.81e-05	0.000184	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—APOB—atherosclerosis	6.8e-05	0.000184	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	6.77e-05	0.000183	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	6.75e-05	0.000182	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—APOB—atherosclerosis	6.74e-05	0.000182	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—EDN1—atherosclerosis	6.72e-05	0.000181	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—MAPK3—atherosclerosis	6.71e-05	0.000181	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—EDN1—atherosclerosis	6.7e-05	0.000181	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IGF1—atherosclerosis	6.69e-05	0.000181	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.68e-05	0.00018	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	6.68e-05	0.00018	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCL5—atherosclerosis	6.66e-05	0.00018	CbGpPWpGaD
Atropine—CHRM3—Metabolism—AGT—atherosclerosis	6.65e-05	0.000179	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCL5—atherosclerosis	6.64e-05	0.000179	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—EDN1—atherosclerosis	6.63e-05	0.000179	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—INS—atherosclerosis	6.63e-05	0.000179	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCL5—atherosclerosis	6.58e-05	0.000178	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCL2—atherosclerosis	6.52e-05	0.000176	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—LPL—atherosclerosis	6.52e-05	0.000176	CbGpPWpGaD
Atropine—CHRM3—Metabolism—APOE—atherosclerosis	6.51e-05	0.000176	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—LPL—atherosclerosis	6.5e-05	0.000175	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—NAMPT—atherosclerosis	6.49e-05	0.000175	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CAV1—atherosclerosis	6.45e-05	0.000174	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.45e-05	0.000174	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—LIPC—atherosclerosis	6.45e-05	0.000174	CbGpPWpGaD
Atropine—CHRM3—Metabolism—APOA1—atherosclerosis	6.44e-05	0.000174	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—LPL—atherosclerosis	6.43e-05	0.000174	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IGF1—atherosclerosis	6.41e-05	0.000173	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—APOC3—atherosclerosis	6.41e-05	0.000173	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—LDLR—atherosclerosis	6.37e-05	0.000172	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—SERPINE1—atherosclerosis	6.36e-05	0.000172	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	6.34e-05	0.000171	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	6.32e-05	0.00017	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	6.25e-05	0.000169	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CETP—atherosclerosis	6.22e-05	0.000168	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SPP1—atherosclerosis	6.17e-05	0.000167	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SPP1—atherosclerosis	6.15e-05	0.000166	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	6.15e-05	0.000166	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	6.13e-05	0.000165	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SPP1—atherosclerosis	6.09e-05	0.000164	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—SERPINE1—atherosclerosis	6.09e-05	0.000164	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NOS3—atherosclerosis	6.07e-05	0.000164	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	6.07e-05	0.000164	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SCARB1—atherosclerosis	5.96e-05	0.000161	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CG—atherosclerosis	5.88e-05	0.000159	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NOS3—atherosclerosis	5.81e-05	0.000157	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.8e-05	0.000157	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	5.71e-05	0.000154	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	5.69e-05	0.000154	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PPARG—atherosclerosis	5.67e-05	0.000153	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	5.64e-05	0.000152	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—HMGCR—atherosclerosis	5.63e-05	0.000152	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AGT—atherosclerosis	5.58e-05	0.00015	CbGpPWpGaD
Atropine—CHRM3—Metabolism—INS—atherosclerosis	5.56e-05	0.00015	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AGT—atherosclerosis	5.56e-05	0.00015	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AGT—atherosclerosis	5.5e-05	0.000149	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—LEP—atherosclerosis	5.46e-05	0.000147	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—APOE—atherosclerosis	5.46e-05	0.000147	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—APOE—atherosclerosis	5.45e-05	0.000147	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—LEP—atherosclerosis	5.45e-05	0.000147	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CAV1—atherosclerosis	5.41e-05	0.000146	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—APOA1—atherosclerosis	5.4e-05	0.000146	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CAV1—atherosclerosis	5.4e-05	0.000146	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—APOE—atherosclerosis	5.39e-05	0.000146	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—LEP—atherosclerosis	5.39e-05	0.000146	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CXCL8—atherosclerosis	5.38e-05	0.000145	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—APOA1—atherosclerosis	5.38e-05	0.000145	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CAV1—atherosclerosis	5.34e-05	0.000144	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—APOA1—atherosclerosis	5.33e-05	0.000144	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ESR1—atherosclerosis	5.22e-05	0.000141	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—AKT1—atherosclerosis	5.2e-05	0.00014	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ESR1—atherosclerosis	5.2e-05	0.00014	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CXCL8—atherosclerosis	5.16e-05	0.000139	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—F2—atherosclerosis	5.15e-05	0.000139	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ESR1—atherosclerosis	5.15e-05	0.000139	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—F2—atherosclerosis	5.14e-05	0.000139	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—IL6—atherosclerosis	5.12e-05	0.000138	CbGpPWpGaD
Atropine—CHRM3—Metabolism—ALB—atherosclerosis	5.1e-05	0.000138	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—F2—atherosclerosis	5.09e-05	0.000137	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.08e-05	0.000137	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ABCA1—atherosclerosis	5.01e-05	0.000135	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—AKT1—atherosclerosis	4.98e-05	0.000134	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	4.93e-05	0.000133	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	4.91e-05	0.000133	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—IL6—atherosclerosis	4.9e-05	0.000132	CbGpPWpGaD
Atropine—CHRM3—Metabolism—NOS3—atherosclerosis	4.88e-05	0.000132	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MMP9—atherosclerosis	4.87e-05	0.000131	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	4.87e-05	0.000131	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NFKB1—atherosclerosis	4.82e-05	0.00013	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MAPK8—atherosclerosis	4.74e-05	0.000128	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—AKT1—atherosclerosis	4.72e-05	0.000127	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	4.72e-05	0.000127	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	4.71e-05	0.000127	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—INS—atherosclerosis	4.67e-05	0.000126	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MMP9—atherosclerosis	4.66e-05	0.000126	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	4.66e-05	0.000126	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—INS—atherosclerosis	4.65e-05	0.000126	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NFKB1—atherosclerosis	4.61e-05	0.000125	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—INS—atherosclerosis	4.61e-05	0.000124	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCL2—atherosclerosis	4.59e-05	0.000124	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCL2—atherosclerosis	4.58e-05	0.000124	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MAPK8—atherosclerosis	4.54e-05	0.000122	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCL2—atherosclerosis	4.53e-05	0.000122	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—AKT1—atherosclerosis	4.52e-05	0.000122	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IGF1—atherosclerosis	4.51e-05	0.000122	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IGF1—atherosclerosis	4.5e-05	0.000121	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PTGS2—atherosclerosis	4.46e-05	0.00012	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IGF1—atherosclerosis	4.46e-05	0.00012	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—VEGFA—atherosclerosis	4.37e-05	0.000118	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—STAT3—atherosclerosis	4.33e-05	0.000117	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—HMOX1—atherosclerosis	4.3e-05	0.000116	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	4.29e-05	0.000116	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	4.27e-05	0.000115	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	4.23e-05	0.000114	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—VEGFA—atherosclerosis	4.19e-05	0.000113	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—STAT3—atherosclerosis	4.15e-05	0.000112	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MAPK3—atherosclerosis	4.14e-05	0.000112	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—APOB—atherosclerosis	4.12e-05	0.000111	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NOS3—atherosclerosis	4.09e-05	0.00011	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NOS3—atherosclerosis	4.08e-05	0.00011	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	4.04e-05	0.000109	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TGFB1—atherosclerosis	4.01e-05	0.000108	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GSTM1—atherosclerosis	4.01e-05	0.000108	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	3.96e-05	0.000107	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—LPL—atherosclerosis	3.94e-05	0.000106	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	3.84e-05	0.000104	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GPX1—atherosclerosis	3.84e-05	0.000104	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CD36—atherosclerosis	3.74e-05	0.000101	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	3.63e-05	9.8e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	3.62e-05	9.77e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	3.58e-05	9.67e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—MTHFR—atherosclerosis	3.54e-05	9.56e-05	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	3.51e-05	9.46e-05	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	3.5e-05	9.43e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PPARA—atherosclerosis	3.48e-05	9.38e-05	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	3.46e-05	9.34e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—IL6—atherosclerosis	3.45e-05	9.32e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—IL6—atherosclerosis	3.44e-05	9.29e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	3.41e-05	9.2e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—AGT—atherosclerosis	3.37e-05	9.09e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—APOE—atherosclerosis	3.3e-05	8.9e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MMP9—atherosclerosis	3.28e-05	8.86e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MMP9—atherosclerosis	3.27e-05	8.83e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CAV1—atherosclerosis	3.27e-05	8.82e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—APOA1—atherosclerosis	3.26e-05	8.8e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	3.25e-05	8.77e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	3.24e-05	8.75e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	3.24e-05	8.74e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	3.21e-05	8.65e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	3.19e-05	8.62e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	3.18e-05	8.59e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	3.18e-05	8.59e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	3.17e-05	8.57e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	3.15e-05	8.51e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	3.14e-05	8.48e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IL6—atherosclerosis	3.02e-05	8.16e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.98e-05	8.03e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	2.95e-05	7.96e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	2.94e-05	7.93e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—STAT3—atherosclerosis	2.92e-05	7.88e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	2.91e-05	7.85e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—STAT3—atherosclerosis	2.91e-05	7.85e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IL6—atherosclerosis	2.9e-05	7.82e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	2.88e-05	7.78e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PPARG—atherosclerosis	2.87e-05	7.75e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—INS—atherosclerosis	2.82e-05	7.6e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—AKT1—atherosclerosis	2.79e-05	7.53e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	2.79e-05	7.53e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	2.78e-05	7.5e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	2.75e-05	7.43e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	2.71e-05	7.3e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	2.7e-05	7.28e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—AKT1—atherosclerosis	2.67e-05	7.21e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	2.67e-05	7.21e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ALB—atherosclerosis	2.58e-05	6.97e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—NOS3—atherosclerosis	2.47e-05	6.67e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PTGS2—atherosclerosis	2.26e-05	6.1e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—AKT1—atherosclerosis	2.24e-05	6.05e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL6—atherosclerosis	2.04e-05	5.5e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL6—atherosclerosis	2.03e-05	5.49e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL6—atherosclerosis	2.01e-05	5.43e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AKT1—atherosclerosis	1.88e-05	5.08e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AKT1—atherosclerosis	1.88e-05	5.06e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.86e-05	5.01e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—AKT1—atherosclerosis	1.14e-05	3.07e-05	CbGpPWpGaD
